AIRS Medical CEO Hyeseong Lee believes that true business success should be measured by improved human health, not by profit from illness. He shares his journey from engineering research to medical school and ultimately to entrepreneurship—driven by a desire to create meaningful, real-world change.

AIRS Medical’s flagship product, SwiftMR, enables faster MRI scans without compromising image quality, significantly improving both patient experience and hospital efficiency. Since entering the U.S. market in 2023, the company has experienced rapid global growth, with more than half of its revenue now coming from the United States. AIRS Medical ultimately envisions a future where early diagnosis and prevention become the norm through accessible, AI-powered imaging.